Transforming brain
mapping with MEG
MEGIN is a global leader in functional neuroimaging, developing innovative
Solutions for Neurology, Neurosurgery & Research.
We are reshaping the field of functional brain imaging, with the aim of ensuring that every scientific advancement translates into meaningful health outcomes for patients worldwide.
Assessing brain function in real-time with MEG supports clinicians and researchers to unravel the mysteries of the human brain and improve the diagnosis and treatment of neurological conditions.
Introducing MEG Maps™
Explore MEG Maps™ – bringing MEG technology into patient care
Seamless scan, database management, and analysis capabilities for presurgical evaluation.
Explore MEG Maps™ – bringing MEG technology into patient care
Seamless scan, database management, and analysis capabilities for presurgical evaluation.
Our MEG solution is used by hospitals
and research institutions worldwide
About MEG technology
What is MEG?
MEG identifies the very small magnetic fields when brain cells are active, to detect and record normal and abnormal brain activity in “real time.” MEG can localize brain function to within a centimeter or even millimeters of the activity. MEG adds to the hemodynamic data obtained from MR technology.
Comfortable patient experience
It is entirely non-invasive, silent, and with no applied magnetic fields, radiation or injections of any kind.
Precise technology for clinical treatment planning
MEG helps doctors locate normal brain activity inluding where the brain processes language, sensory, and motor information to help plan surgical and non-surgical treatments. MEG is unaffected by the skull and scalp, or hemodynamic data like MR.
MEG is an important part of pre-surgical evaluation
MEG Maps™ is designed to push the boundaries of neuroscience by augmenting the performance limitations of traditional MR imaging modalities, providing neuroscientists, neurologists and oncologists with a more advanced and precise functional imaging tool.
MEG is used alongside other functional brain mapping methods, such as fMRI, PET, SPECT, and TMS, to non-invasively provide clinicians with a more complete picture of the location of a patient’s normal and abnormal brain activity. MEG can assist in the presurgical evaluation and treatment planning, specifically the placement of intracranial EEG (iEEG).
MEG is an important part of a research program
Thousands of patients are participating in clinical MEG studies focusing on epilepsy, brain tumors, traumatic brain injuries, PTSD, stroke, dementias, Parkinson’s, and other neurodegenerative disorders.
MEG can be a valuable tool in Phase I & III pharmaceutical drug development as it allows researchers to gain insights into the neural mechanisms underlying the effects of a drug.
Thousands of patients are participating in clinical MEG studies focusing on epilepsy, brain tumors, traumatic brain injuries, PTSD, stroke, dementias, Parkinson’s, and other neurodegenerative disorders.
MEG can be a valuable tool in Phase I & III pharmaceutical drug development as it allows researchers to gain insights into the neural mechanisms underlying the effects of a drug.
Learn from MEG thought leaders
See how MEG technology is being used in clinical and research settings around the world. Watch our free Spotlight and Masterclass series with key thought leaders, physicians, scientists and researchers
Dive into MEGIN Spotlights for engaging conversations with thought leaders, partners, customers, and caregivers as they offer unique insights and experiences with MEG.
Join our 1-hour MEGIN Masterclass sessions and learn from leading experts in MEG technology. Featuring an array of key opinion and thought leaders and a chance to learn with the wider, global community.